Stellar Biotechnologies specializes in the production of KLH (keyhole limpet hemocyanin), a powerful immune-stimulating protein used in a new class of drugs known as conjugate vaccines. KLH is used as an essential carrier protein in vaccines being developed for use in Oncology, Cardiology, Rheumatology, Neurology, and as an antigen in Immune Function Testing. Stellar has generated IP (Intellectual Property) related to the selection, processing, and purification of this valuable protein. The company is headquartered in California.  For more information, visit the company’s Web site at www.stellarbiotechnologies.com